<?xml version="1.0" encoding="UTF-8"?>
<p id="p0120">Virus-specific antibodies present in CPT have been used as late-line treatments in recent epidemics including SARS, Ebola, H1N1 influenza, and MERS and throughout the history of medicine.
 <xref rid="bib101" ref-type="bibr">
  <sup>101</sup>
 </xref> A retrospective study of therapeutic plasma exchange in patients with sepsis and multiorgan failure that is currently under peer review suggests that for patients with pneumonia as the primary source of sepsis, this approach may improve mortality rates.
 <xref rid="bib102" ref-type="bibr">
  <sup>102</sup>
 </xref>
</p>
